AstraZeneca Pharma India Limited Stock NSE India S.E.
Equities
ASTRAZEN
INE203A01020
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,190 INR | -0.66% | -2.22% | -6.10% |
Sales 2022 | 8.06B 96.67M | Sales 2023 | 10.03B 120M | Capitalization | 81.18B 974M |
---|---|---|---|---|---|
Net income 2022 | 616M 7.39M | Net income 2023 | 993M 11.92M | EV / Sales 2022 | 7.38 x |
Net cash position 2022 | 4.4B 52.77M | Net cash position 2023 | 4.93B 59.18M | EV / Sales 2023 | 7.6 x |
P/E ratio 2022 |
104
x | P/E ratio 2023 |
81.8
x | Employees | - |
Yield 2022 |
0.39% | Yield 2023 |
0.49% | Free-Float | 17.58% |
1 day | -0.66% | ||
1 week | -2.22% | ||
Current month | -2.60% | ||
1 month | +2.33% | ||
3 months | -17.61% | ||
6 months | +11.39% | ||
Current year | -6.10% |
Managers | Title | Age | Since |
---|---|---|---|
Siva Padmanabhan
CEO | Chief Executive Officer | - | - |
Sanjeev Panchal
CEO | Chief Executive Officer | - | 03-01-31 |
Bhavana Agrawal
DFI | Director of Finance/CFO | - | 23-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Revathy Ashok
BRD | Director/Board Member | 65 | 16-12-01 |
Chairman | 67 | 12-12-05 | |
Director/Board Member | 50 | 21-12-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 5,190 | -0.66% | 22,305 |
24-04-18 | 5,224 | -1.15% | 13,097 |
24-04-16 | 5,285 | +1.64% | 5,299 |
24-04-15 | 5,200 | -2.03% | 25,650 |
24-04-12 | 5,308 | -1.68% | 5,214 |
Delayed Quote NSE India S.E., April 19, 2024 at 07:43 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+24.60% | 672B | |
+24.08% | 550B | |
-5.63% | 351B | |
+15.37% | 317B | |
+7.38% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.69% | 144B | |
-6.63% | 141B |
- Stock Market
- Equities
- ASTRAZEN Stock
- ASTRAZEN Stock